Subcellular localization and stability of MITF are modulated by the bHLH-Zip domain

被引:22
作者
Fock, Valerie [1 ]
Gudmundsson, Sigurdur Runar [1 ]
Gunnlaugsson, Hilmar Orn [1 ]
Stefansson, Jon August [1 ]
Ionasz, Vivien [1 ]
Schepsky, Alexander [1 ]
Viarigi, Jade [1 ]
Reynisson, Indridi Einar [1 ]
Pogenberg, Vivian [2 ]
Wilmanns, Matthias [2 ]
Ogmundsdottir, Margret Helga [1 ]
Steingrimsson, Eirikur [1 ]
机构
[1] Univ Iceland, Fac Med, Dept Biochem & Mol Biol, Biomed Ctr, Sturlugata 8, IS-101 Reykjavik, Iceland
[2] DESY, EMBL Hamburg, Hamburg, Germany
基金
奥地利科学基金会;
关键词
bHLH-Zip; MITF; nuclear localization; stability; Waardenburg syndrome; MICROPHTHALMIA; MUTATIONS; WAARDENBURG; MELANOMA; GENE; PREDISPOSES; MECHANISM; AUTOPHAGY; LYSOSOME; MOUSE;
D O I
10.1111/pcmr.12721
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microphthalmia-associated transcription factor (MITF) is a member of the basic helix-loop-helix leucine zipper (bHLH-Zip) family and functions as the master regulator of the melanocytic lineage. MITF-M is the predominant isoform expressed in melanocytes and melanoma cells, and, unlike other MITF isoforms, it is constitutively nuclear. Mutational analysis revealed three karyophilic signals in the bHLH-Zip domain of MITF-M, spanning residues 197-206, 214-217, and 255-265. Structural characterization of the MITF protein showed that basic residues within these signals are exposed for interactions in the absence of DNA. Moreover, our data indicate that neither DNA binding nor dimerization of MITF-M are required for its nuclear localization. Finally, dimerization-deficient MITF-M mutants exhibited a significantly reduced stability in melanoma cells when compared to the wild-type protein. Taken together, we have shown that, in addition to its well-established role in DNA binding and dimer formation, the bHLH-Zip domain of MITF modulates the transcription factor's subcellular localization and stability.
引用
收藏
页码:41 / 54
页数:14
相关论文
共 37 条
  • [1] A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
    Bertolotto, Corine
    Lesueur, Fabienne
    Giuliano, Sandy
    Strub, Thomas
    de Lichy, Mahaut
    Bille, Karine
    Dessen, Philippe
    d'Hayer, Benoit
    Mohamdi, Hamida
    Remenieras, Audrey
    Maubec, Eve
    de la Fouchardiere, Arnaud
    Molinie, Vincent
    Vabres, Pierre
    Dalle, Stephane
    Poulalhon, Nicolas
    Martin-Denavit, Tanguy
    Thomas, Luc
    Andry-Benzaquen, Pascale
    Dupin, Nicolas
    Boitier, Francoise
    Rossi, Annick
    Perrot, Jean-Luc
    Labeille, Bruno
    Robert, Caroline
    Escudier, Bernard
    Caron, Olivier
    Brugieres, Laurence
    Saule, Simon
    Gardie, Betty
    Gad, Sophie
    Richard, Stephane
    Couturier, Jerome
    Teh, Bin Tean
    Ghiorzo, Paola
    Pastorino, Lorenza
    Puig, Susana
    Badenas, Celia
    Olsson, Hakan
    Ingvar, Christian
    Rouleau, Etienne
    Lidereau, Rosette
    Bahadoran, Philippe
    Vielh, Philippe
    Corda, Eve
    Blanche, Helene
    Zelenika, Diana
    Galan, Pilar
    Chaudru, Valerie
    Lenoir, Gilbert M.
    [J]. NATURE, 2011, 480 (7375) : 94 - U259
  • [2] Bharti K, 2010, METHODS MOL BIOL, V647, P237, DOI 10.1007/978-1-60761-738-9_14
  • [3] Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors
    Bronisz, Agnieszka
    Sharma, Sudarshana M.
    Hu, Rong
    Godlewski, Jakub
    Tzivion, Guri
    Mansky, Kim C.
    Ostrowski, Michael C.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (09) : 3897 - 3906
  • [4] Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny
    Cheli, Y.
    Guiliano, S.
    Botton, T.
    Rocchi, S.
    Hofman, V.
    Hofman, P.
    Bahadoran, P.
    Bertolotto, C.
    Ballotti, R.
    [J]. ONCOGENE, 2011, 30 (20) : 2307 - 2318
  • [5] Frequent mutations in the MITF pathway in melanoma
    Cronin, Julia C.
    Wunderlich, John
    Loftus, Stacie K.
    Prickett, Todd D.
    Wei, Xiaomu
    Ridd, Katie
    Vemula, Swapna
    Burrell, Allison S.
    Agrawal, Neena S.
    Lin, Jimmy C.
    Banister, Carolyn E.
    Buckhaults, Phillip
    Rosenberg, Steven A.
    Bastian, Boris C.
    Pavan, William J.
    Samuels, Yardena
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2009, 22 (04) : 435 - 444
  • [6] IDENTIFICATION OF THE HUMAN C-MYC PROTEIN NUCLEAR TRANSLOCATION SIGNAL
    DANG, CV
    LEE, WMF
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (10) : 4048 - 4054
  • [7] Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
    Garraway, LA
    Widlund, HR
    Rubin, MA
    Getz, G
    Berger, AJ
    Ramaswamy, S
    Beroukhim, R
    Milner, DA
    Granter, SR
    Du, JY
    Lee, C
    Wagner, SN
    Li, C
    Golub, TR
    Rimm, DL
    Meyerson, ML
    Fisher, DE
    Sellers, WR
    [J]. NATURE, 2005, 436 (7047) : 117 - 122
  • [8] Biallelic Mutations in MITF Cause Coloboma, Osteopetrosis, Microphthalmia, Macrocephaly, Albinism, and Deafness
    George, Aman
    Zand, Dina J.
    Hufnagel, Robert B.
    Sharma, Ruchi
    Sergeev, Yuri V.
    Legare, Janet M.
    Rice, Gregory M.
    Schwoerer, Jessica A. Scott
    Rius, Mariana
    Tetri, Laura
    Gamm, David M.
    Bharti, Kapil
    Brooks, Brian P.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2016, 99 (06) : 1388 - 1394
  • [9] MITF mutations associated with pigment deficiency syndromes and melanoma have different effects on protein function
    Grill, Christine
    Bergsteinsdottir, Kristin
    Oegmundsdottir, Margret H.
    Pogenberg, Vivian
    Schepsky, Alexander
    Wilmanns, Matthias
    Pingault, Veronique
    Steingrimsson, Eirikur
    [J]. HUMAN MOLECULAR GENETICS, 2013, 22 (21) : 4357 - 4367
  • [10] MICROPHTHALMIA, A CRITICAL FACTOR IN MELANOCYTE DEVELOPMENT, DEFINES A DISCRETE TRANSCRIPTION FACTOR FAMILY
    HEMESATH, TJ
    STEINGRIMSSON, E
    MCGILL, G
    HANSEN, MJ
    VAUGHT, J
    HODGKINSON, CA
    ARNHEITER, H
    COPELAND, NG
    JENKINS, NA
    FISHER, DE
    [J]. GENES & DEVELOPMENT, 1994, 8 (22) : 2770 - 2780